Mauna Kea Technologies SA (EPA:ALMKT)

Market Cap	29.62M +177.8%
Revenue (ttm)	8.91M +5.9%
Net Income	10.77M
EPS	0.10
Shares Out	192.84M
PE Ratio	1.60
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	168,060
Open	0.1550
Previous Close	0.1560
Day's Range	0.1510 - 0.1558
52-Week Range	0.0692 - 0.2315
Beta	0.97
Analysts	Buy
Price Target	3.00 (+1,853.13%)
Earnings Date	Oct 8, 2026

About Mauna Kea Technologies

Mauna Kea Technologies SA manufactures and sells medical devices in Europe and internationally. It offers a range of medical devices for gastroenterology, pulmonology, and urology applications. Its product portfolio includes Cellvizio, a real-time in vivo cellular imaging platform that enables unique in vivo cellular visualization, allowing doctors to monitor disease evolution over time, evaluate reactions as they occur, classify areas of uncertainty, guide surgical interventions, and help diagnose and treat patients. The company was incorporat...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2000
• Employees: 59
• Stock Exchange: Euronext Paris
• Ticker Symbol: ALMKT

Financial Performance

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Jun 19, 2026

Data Sources Report a data error